Published in Clin Infect Dis on October 19, 2011
Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One (2013) 1.69
Cryptococcus gattii infections. Clin Microbiol Rev (2014) 1.55
Cryptococcus gattii: the tip of the iceberg. Clin Infect Dis (2011) 1.47
Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal. MBio (2014) 1.45
Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS One (2012) 1.31
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother (2012) 1.28
Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis. MBio (2012) 1.28
Management of Cryptococcus gattii meningoencephalitis. Lancet Infect Dis (2014) 1.12
DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans. PLoS Pathog (2012) 1.11
Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates. PLoS One (2013) 1.10
Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis (2013) 1.09
Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc (2013) 1.07
Current trends in the prevalence of Cryptococcus gattii in the United States and Canada. Infect Drug Resist (2015) 1.06
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother (2012) 1.02
Invasive fungal infections in solid organ transplant recipients. Future Microbiol (2012) 1.01
Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii. MBio (2015) 0.99
Name Changes for Fungi of Medical Importance, 2012 to 2015. J Clin Microbiol (2016) 0.96
Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One (2011) 0.94
Cryptococcus gattii as an important fungal pathogen of western North America. Expert Rev Anti Infect Ther (2012) 0.87
Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis. PLoS Pathog (2015) 0.87
An encapsulation of iron homeostasis and virulence in Cryptococcus neoformans. Trends Microbiol (2013) 0.87
Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol (2015) 0.85
Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method. Antimicrob Agents Chemother (2014) 0.85
Disseminated cryptococcosis initially presenting as cellulitis in a patient suffering from nephrotic syndrome. BMC Nephrol (2013) 0.85
Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest. PLoS One (2014) 0.84
Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11. Antimicrob Agents Chemother (2013) 0.83
Cryptococcal Meningitis: Diagnosis and Management Update. Curr Trop Med Rep (2015) 0.83
Rare Cryptococus gattii infection in an immunocompetent dairy goat following a cesarean section. Med Mycol Case Rep (2012) 0.81
Recognition and diagnosis of Cryptococcus gattii infections in the United States. Emerg Infect Dis (2012) 0.80
Recent Taxonomic Developments with Candida and Other Opportunistic Yeasts. Curr Fungal Infect Rep (2012) 0.80
Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates. Front Microbiol (2016) 0.79
Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans. J Antimicrob Chemother (2015) 0.79
Literature-based gene curation and proposed genetic nomenclature for cryptococcus. Eukaryot Cell (2014) 0.79
MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors. PLoS Negl Trop Dis (2016) 0.77
Fungal infections of the gastrointestinal tract in the immunocompromised host: an update. Adv Anat Pathol (2014) 0.77
Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011. PLoS Negl Trop Dis (2014) 0.77
Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates. Sci Rep (2015) 0.76
Primary cutaneous cryptococcosis caused by Cryptococcus gattii VGII in a tsunami survivor from Thailand. Med Mycol Case Rep (2014) 0.75
The Brief Case: Cryptococcus gattii Meningitis with Ventriculitis. J Clin Microbiol (2016) 0.75
Cryptococcus gattii Genotype VGIIa Infection in an Immunocompetent Japanese Patient: A Case Report and Mini-review. Intern Med (2016) 0.75
Emerging and reemerging neurologic infections. Neurohospitalist (2014) 0.75
Skeletal cryptococcosis from 1977 to 2013. Front Microbiol (2015) 0.75
Sex and gender bias in anatomy and physical diagnosis text illustrations. JAMA (1994) 7.51
Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med (1971) 6.55
In vivo high-resolution video-rate spectral-domain optical coherence tomography of the human retina and optic nerve. Opt Express (2004) 4.96
A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA (1994) 4.85
Ultrahigh-resolution high-speed retinal imaging using spectral-domain optical coherence tomography. Opt Express (2004) 4.72
Case-finding for depression in primary care: a randomized trial. Am J Med (1999) 4.46
Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J (1999) 4.34
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
In vivo dynamic human retinal blood flow imaging using ultra-high-speed spectral domain optical coherence tomography. Opt Express (2003) 4.00
The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci U S A (1997) 3.75
Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat Med (1997) 3.55
Crystal structure of the yeast TFIIA/TBP/DNA complex. Science (1996) 3.45
Estimating the growth rate of slowly growing marine bacteria from RNA content. Appl Environ Microbiol (1993) 3.45
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat (2011) 3.40
Switchable ferroelectric diode and photovoltaic effect in BiFeO3. Science (2009) 3.39
T-DNA insertional mutagenesis for functional genomics in rice. Plant J (2000) 3.25
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
A Smad transcriptional corepressor. Cell (1999) 3.07
Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol (1986) 2.94
The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol (2000) 2.90
Real-time fiber-based multi-functional spectral-domain optical coherence tomography at 1.3 microm. Opt Express (2005) 2.83
Dyspepsia is strongly associated with major depression and generalised anxiety disorder - a community study. Aliment Pharmacol Ther (2012) 2.80
The crystal structure of the peptide-binding fragment from the yeast Hsp40 protein Sis1. Structure (2000) 2.80
Paediatric hand fractures. J Hand Surg Eur Vol (2013) 2.65
Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta (1996) 2.64
A quasi-monoclonal mouse. Science (1996) 2.58
Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol (1993) 2.57
Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis (1988) 2.56
Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils. J Exp Med (1991) 2.52
Knowledge and attitudes about depression among non-generalists and generalists. J Fam Pract (1997) 2.51
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol (2012) 2.46
High-speed spectral-domain optical coherence tomography at 1.3 mum wavelength. Opt Express (2003) 2.45
Ohm's law survives to the atomic scale. Science (2012) 2.40
The mosaic organization of the apocytochrome b gene of Aspergillus nidulans revealed by DNA sequencing. Cell (1981) 2.38
Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia (2008) 2.37
Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis (2000) 2.35
Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J Clin Microbiol (1997) 2.35
Update on Hsp90 inhibitors in clinical trial. Curr Top Med Chem (2009) 2.34
Retinal nerve fiber layer thickness map determined from optical coherence tomography images. Opt Express (2005) 2.27
The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell (1992) 2.25
The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science (1992) 2.23
Reaching our successors: the trend for early specialisation and the potential effect on recruitment to our speciality. J Plast Reconstr Aesthet Surg (2008) 2.21
CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med (1996) 2.21
Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity (1997) 2.18
Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis (1998) 2.15
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes (Lond) (2006) 2.11
The tomato Never-ripe locus regulates ethylene-inducible gene expression and is linked to a homolog of the Arabidopsis ETR1 gene. Plant Physiol (1995) 2.11
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am J Pathol (1977) 2.08
Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med (1981) 2.07
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun (1994) 2.07
1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med (1999) 1.98
A theoretical model for the margination of particles within blood vessels. Ann Biomed Eng (2005) 1.97
Cytokinins and auxins control the expression of a gene in Nicotiana plumbaginifolia cells by feedback regulation. Plant Cell (1992) 1.95
Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry (1998) 1.94
Multiresistant Salmonella Typhimurium DT104 infections of humans and domestic animals in the Pacific Northwest of the United States. Epidemiol Infect (2000) 1.89
Immunologic competence of thoracic duct cells. I. Delayed hypersensitivity. J Exp Med (1966) 1.89
Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax (2006) 1.86
Signals for retention of transmembrane proteins in the endoplasmic reticulum studied with CD4 truncation mutants. Proc Natl Acad Sci U S A (1991) 1.86
Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol (2001) 1.83
Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol (1995) 1.82
Use of OSHA inspections data for fatal occupational injury surveillance in New Jersey. Am J Public Health (1990) 1.81
BAX protein expression and clinical outcome in epithelial ovarian cancer. J Clin Oncol (1998) 1.80
International application of a new probability algorithm for the diagnosis of coronary artery disease. Am J Cardiol (1989) 1.77
Molecular design of aquaporin-1 water channel as revealed by electron crystallography. Nat Struct Biol (1997) 1.77
A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group. Hepatology (1999) 1.75
Saccharomyces cerevisiae MSH2, a mispaired base recognition protein, also recognizes Holliday junctions in DNA. J Mol Biol (1997) 1.71
Structure of Semliki Forest virus core protein. Proteins (1997) 1.70
Renal homotransplantation in rats. I. Allogeneic recipients. J Exp Med (1967) 1.68
Isolation and characterization of toluene-sensitive mutants from the toluene-resistant bacterium Pseudomonas putida GM73. J Bacteriol (1998) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest (2000) 1.65
Borderline personality disorder symptoms and severity of sexual abuse. Am J Psychiatry (1995) 1.65
Definition and assessment of accuracy in social stereotypes. Psychol Rev (1993) 1.65
Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol (2001) 1.64
Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. J Biol Chem (1991) 1.62
leafy hull sterile1 is a homeotic mutation in a rice MADS box gene affecting rice flower development. Plant Cell (2000) 1.62
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol (1995) 1.62
Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. JAMA (1981) 1.62
Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum (1996) 1.61
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol (1992) 1.61
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci U S A (1995) 1.61
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci U S A (2001) 1.59
The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci U S A (1998) 1.59
Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles. Tissue Antigens (1995) 1.59
Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol (1999) 1.58
Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2006) 1.57
Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J Immunol Methods (1988) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety. Leukemia (2013) 1.56
Cutaneous aspergillosis and acquired immunodeficiency syndrome. Arch Dermatol (2000) 1.55
A self-supporting library service in a rural region: a new look at hospital consortia. Bull Med Libr Assoc (1982) 1.54
Homogeneous NMR spectra in inhomogeneous fields. Science (1996) 1.54
Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. J Clin Microbiol (1998) 1.53
Alloxan diabetic neuropathy: electron microscopic studies. Neurology (1977) 1.53
Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol (1997) 1.52
Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. Hepatology (1994) 1.52